|
|
| Line 1: |
Line 1: |
| {{Seed}}
| |
| [[Image:3bdj.png|left|200px]] | | [[Image:3bdj.png|left|200px]] |
|
| |
|
| Line 20: |
Line 19: |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| 3BDJ is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3BDJ OCA].
| | [[3bdj]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3BDJ OCA]. |
|
| |
|
| ==Reference== | | ==Reference== |
| Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol., Okamoto K, Eger BT, Nishino T, Pai EF, Nishino T, Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):888-93. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18600558 18600558]
| | <ref group="xtra">PMID:18600558</ref><ref group="xtra">PMID:11796116</ref><ref group="xtra">PMID:15148401</ref><ref group="xtra">PMID:15190124</ref><ref group="xtra">PMID:12421831</ref><references group="xtra"/> |
| | |
| Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus., Truglio JJ, Theis K, Leimkuhler S, Rappa R, Rajagopalan KV, Kisker C, Structure. 2002 Jan;10(1):115-25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11796116 11796116]
| |
| | |
| The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition., Okamoto K, Matsumoto K, Hille R, Eger BT, Pai EF, Nishino T, Proc Natl Acad Sci U S A. 2004 May 25;101(21):7931-6. Epub 2004 May 17. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15148401 15148401]
| |
| | |
| Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion., Fukunari A, Okamoto K, Nishino T, Eger BT, Pai EF, Kamezawa M, Yamada I, Kato N, J Pharmacol Exp Ther. 2004 Nov;311(2):519-28. Epub 2004 Jun 9. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15190124 15190124]
| |
| | |
| An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition., Okamoto K, Eger BT, Nishino T, Kondo S, Pai EF, Nishino T, J Biol Chem. 2003 Jan 17;278(3):1848-55. Epub 2002 Nov 5. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12421831 12421831]
| |
| [[Category: Bos taurus]] | | [[Category: Bos taurus]] |
| [[Category: Eger, B T.]] | | [[Category: Eger, B T.]] |
| Line 51: |
Line 42: |
| [[Category: Xanthine oxidase]] | | [[Category: Xanthine oxidase]] |
| [[Category: Xanthine oxidoreductase]] | | [[Category: Xanthine oxidoreductase]] |
|
| |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Dec 5 09:58:31 2008''
| |
